SCHEMBL28433296

SCHEMBL28433296

Cc1ccc2c(=O)c(C(=O)O)c(-c3ccc(Cl)cc3)oc2c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.63
ALDH1A1 P00352 3/20 0.63
KDM4E B2RXH2 2/20 0.63
HTT P42858 2/20 0.63
MEN1 O00255 1/20 0.63
NPC1 O15118 1/20 0.63
HPGD P15428 1/20 0.63
RAB9A P51151 1/20 0.63
KMT2A Q03164 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
CSNK2A2 P19784 2/20 0.56
CSNK2B P67870 2/20 0.56
CSNK2A1 P68400 2/20 0.56
TP53 P04637 2/20 0.56
DHODH Q02127 2/20 0.47
TTR P02766 2/20 0.46
ANO1 Q5XXA6 2/20 0.45
ALOX5 P09917 1/20 0.45
MCL1 Q07820 1/20 0.44
TSHR P16473 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22284779 0.90 MAPT (0.79) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL31723133 0.90 MAPT (0.79) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL31723177 0.85 ALDH1A1 (0.57) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL20918269 0.85 ALDH1A1 (0.57) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL31723140 0.84 MAPT (0.59) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL20919306 0.84 MAPT (0.59) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL28431175 0.83 MAPT (0.68) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL31723158 0.83 MAPT (0.68) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL20919240 0.82 MAPT (0.60) MAPTALDH1A1KDM4EHTTMEN1
SCHEMBL31723154 0.82 MAPT (0.60) MAPTALDH1A1KDM4EHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed
CN-111315730-A Composition for preventing or treating tumor necrosis factor-related diseases comprising novel derivative as active ingredient and method for inhibiting tumor necrosis factor activity using the same 艾伊莱布 2020-06-19 CN claimed
CN-111315730-A Composition for preventing or treating tumor necrosis factor-related diseases comprising novel derivative as active ingredient and method for inhibiting tumor necrosis factor activity using the same 艾伊莱布 2020-06-19 CN disclosed